Oregon Health and Science University Dept. Hematologic Malignancies is a clinical research site located in Portland, Oregon, United States 97239.
Crixeo Clinical Trials Trust Score: 95/100 (GOOD). This profile has not yet been claimed by the site owner.
Oregon Health and Science University Dept. Hematologic Malignancies has participated in 1 clinical trials.
Therapeutic areas: Leukemia.
Sponsors: Novartis Pharmaceuticals.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Oregon · View every site in Portland
Trust Score: 95/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Oregon Health and Science University Dept. Hematologic Malignancies has a Crixeo Trust Score of 95/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Oregon Health and Science University Dept. Hematologic Malignancies has 1 clinical trials on record. Their work covers Leukemia.
Oregon Health and Science University Dept. Hematologic Malignancies has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.